These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21109767)

  • 1. Hyperhomocysteinemia: a renal and cardiovascular risk factor?
    Zoccali C; Jager KJ
    Nat Rev Nephrol; 2010 Dec; 6(12):695-6. PubMed ID: 21109767
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine lowering and cardiovascular disease risk: lost in translation.
    Marcus J; Sarnak MJ; Menon V
    Can J Cardiol; 2007 Jul; 23(9):707-10. PubMed ID: 17622392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic B-vitamin therapy for hyperhomocysteinemia in dialysis patients: has the time come?
    Friedman AN
    Nutr Clin Care; 2002; 5(1):20-4. PubMed ID: 12134715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of vitamin B therapy on bone and cardiovascular disease.
    Righetti M
    Recent Pat Cardiovasc Drug Discov; 2009 Jan; 4(1):37-44. PubMed ID: 19149705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine, B vitamins, and cardiovascular disease.
    Refsum H; Smith AD
    N Engl J Med; 2006 Jul; 355(2):207; author reply 209-11. PubMed ID: 16848014
    [No Abstract]   [Full Text] [Related]  

  • 6. Homocysteine, B vitamins, and cardiovascular disease.
    Wang X; Demirtas H; Xu X
    N Engl J Med; 2006 Jul; 355(2):207-9; author reply 209-11. PubMed ID: 16838445
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperhomocysteinemia in chronic renal disease.
    Bostom AG; Culleton BF
    J Am Soc Nephrol; 1999 Apr; 10(4):891-900. PubMed ID: 10203375
    [No Abstract]   [Full Text] [Related]  

  • 8. Homocysteine, B vitamins, and cardiovascular disease.
    Quinlivan EP; Gregory JF
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16838446
    [No Abstract]   [Full Text] [Related]  

  • 9. Homocysteine, B vitamins, and cardiovascular disease.
    Tomlinson DR; Lang D; Lewis MJ
    N Engl J Med; 2006 Jul; 355(2):209; author reply 209-11. PubMed ID: 16838444
    [No Abstract]   [Full Text] [Related]  

  • 10. Homocysteine, B vitamins, and cardiovascular disease.
    Khare A; Lopez M; Gogtay J
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16848015
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of a supplementation with vitamins on cardiovascular morbidity and mortality in patients with end-stage renal disease: design and baseline data of a randomized clinical trial.
    Heinz J; Domröse U; Luley C; Westphal S; Kropf S; Neumann KH; Dierkes J
    Clin Nephrol; 2009 Mar; 71(3):363-5. PubMed ID: 19281755
    [No Abstract]   [Full Text] [Related]  

  • 12. Homocysteine, B vitamins, and cardiovascular disease.
    de Craen AJ; Stott DJ; Westendorp RG
    N Engl J Med; 2006 Jul; 355(2):205-6; author reply 209-11. PubMed ID: 16837687
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vascular risk factors].
    Renou P
    Presse Med; 2002 Oct; 31(34):1624-8. PubMed ID: 12426981
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial.
    House AA; Eliasziw M; Cattran DC; Churchill DN; Oliver MJ; Fine A; Dresser GK; Spence JD
    JAMA; 2010 Apr; 303(16):1603-9. PubMed ID: 20424250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention: B vitamins and CVD--failure to find a simple solution.
    Ebbing M; Ueland PM
    Nat Rev Cardiol; 2010 Nov; 7(11):608-9. PubMed ID: 20975658
    [No Abstract]   [Full Text] [Related]  

  • 16. The controversial role of B-vitamins in cardiovascular risk: An update.
    Ntaios G; Savopoulos C; Grekas D; Hatzitolios A
    Arch Cardiovasc Dis; 2009 Dec; 102(12):847-54. PubMed ID: 19963194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia as a risk factor for cardiovascular diseases. The association of hyperhomocysteinemia with diabetes mellitus and renal transplant recipients.
    Socha MW; Polakowska MJ; Socha-Urbanek K; Fiedor P
    Ann Transplant; 1999; 4(1):11-9. PubMed ID: 10850596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia in chronic renal failure: alternative therapeutic strategies.
    Perna AF; Sepe I; Lanza D; Pollastro RM; De Santo NG; Ingrosso D
    J Ren Nutr; 2012 Jan; 22(1):191-4. PubMed ID: 22200441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction.
    Ciaccio M; Bellia C
    Curr Clin Pharmacol; 2010 Feb; 5(1):30-6. PubMed ID: 20236081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.